Common Use of Stimulants and Alpha-2 Agonists to Treat Preschool Attention-Deficit Hyperactivity Disorder: A DBPNet Study

Journal of Developmental and Behavioral Pediatrics : JDBP
Nathan J BlumWilliam J Barbaresi

Abstract

To describe the use of stimulants and alpha-2 agonists (A2As) for the treatment of preschool-aged children with attention-deficit hyperactivity disorder (ADHD) at 2 Developmental-Behavioral Pediatrics Research Network sites. Demographic information, diagnoses, and medications prescribed by developmental-behavioral pediatricians (DBPs) were extracted from the electronic health record for all outpatient visits from January 1, 2010, to December 31, 2011. The subset of visits for children aged 2 to 5 years who had a diagnosis of ADHD was included in this analysis. Multivariable models were constructed to identify factors associated with prescribing stimulants and A2As. Over the 2-year period, 984 children with a diagnosis of ADHD were seen at 1779 visits. Of the 984 children, 342 (34.8%) were prescribed a stimulant, and 243 (24.7%) were prescribed an A2A. Both medications were prescribed at the same visit at least once during the 2-year period for 97 children (9.9%). Alpha-2 agonists were prescribed more often at site 2 than site 1 (OR [odds ratio] = 1.62, p = 0.015). Stimulants were more likely to be prescribed for older preschool-aged children (OR = 1.66, p < 0.001), and A2As were more likely to be prescribed for younger children...Continue Reading

References

Jan 1, 1995·Journal of the American Academy of Child and Adolescent Psychiatry·R D HuntM D Asbell
Jun 24, 2005·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Elana Greenfield Spira, Janet E Fischel
Oct 7, 2006·Journal of the American Academy of Child and Adolescent Psychiatry·Laurence GreenhillTom Cooper
Oct 10, 2006·Journal of the American Academy of Child and Adolescent Psychiatry·Tim WigalAnnamarie Stehli
May 11, 2007·Journal of Child and Adolescent Psychopharmacology·Julie M ZitoDonald R Mattison
Nov 6, 2007·Journal of Child and Adolescent Psychopharmacology·Jaswinder K GhumanAnne M Skrobala
Nov 22, 2007·Journal of the American Academy of Child and Adolescent Psychiatry·Mary Margaret GleasonCharles H Zeanah
Feb 11, 2009·Journal of Tropical Pediatrics·Vrinda Nair, S Mahadevan
Sep 22, 2010·Journal of the American Academy of Child and Adolescent Psychiatry·Jonathan S ComerRamin Mojtabai
Mar 23, 2011·Pediatrics·Christopher J KratochvilJohn S March
Oct 18, 2011·Pediatrics·UNKNOWN Subcommittee on Attention-Deficit/Hyperactivity DisorderSusanna Visser
Jan 30, 2014·Journal of the American Academy of Child and Adolescent Psychiatry·Tomoya HirotaChristoph U Correll
Sep 16, 2014·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Julie L FierroJeffrey S Gerber
Dec 3, 2014·Academic Pediatrics·Heidi M FeldmanUNKNOWN DBPNet Steering Committee
Oct 16, 2015·Pediatrics·L Elizabeth AndersonJeanne Van Cleave
Jul 19, 2016·Journal of Developmental and Behavioral Pediatrics : JDBP·Elizabeth HarstadWilliam Barbaresi
Jul 8, 2017·The Journal of Clinical Psychiatry·Almut G WintersteinMark Olfson

❮ Previous
Next ❯

Citations

Jan 31, 2020·Journal of Developmental and Behavioral Pediatrics : JDBP·Elizabeth A Diekroger, Tanya E Froehlich
Jul 3, 2020·Journal of Child and Adolescent Psychopharmacology·Deborah Winders DavisNatalie Pasquenza
May 5, 2021·JAMA : the Journal of the American Medical Association·Tanya E Froehlich
May 5, 2021·JAMA : the Journal of the American Medical Association·Elizabeth HarstadNathan J Blum
May 1, 2021·Journal of Developmental and Behavioral Pediatrics : JDBP·Elizabeth HarstadNathan Blum
Sep 3, 2021·Oxidative Medicine and Cellular Longevity·Natália Cruz-MartinsWilliam C Cho

❮ Previous
Next ❯

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.